Compare TENB & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TENB | FMC |
|---|---|---|
| Founded | 2002 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2018 | 1994 |
| Metric | TENB | FMC |
|---|---|---|
| Price | $20.17 | $14.39 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 13 |
| Target Price | ★ $34.70 | $17.75 |
| AVG Volume (30 Days) | 2.4M | ★ 2.7M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.16% |
| EPS Growth | ★ 3.23 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $999,405,000.00 | ★ $4,727,800,000.00 |
| Revenue This Year | $9.37 | $8.01 |
| Revenue Next Year | $7.04 | $4.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.04 | N/A |
| 52 Week Low | $17.28 | $12.17 |
| 52 Week High | $37.90 | $44.77 |
| Indicator | TENB | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 45.10 | 49.22 |
| Support Level | $19.15 | $12.85 |
| Resistance Level | $21.29 | $14.55 |
| Average True Range (ATR) | 0.90 | 0.73 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 62.55 | 57.46 |
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.